De novo mTOR inhibitor immunosuppression versus calcineurin inhibitor immunosuppression for liver transplant recipients
Sophie Kollbeck, Julia‐Kristin Graß, Jens Hillingsø, Luit Penninga
Abstract
Sophie Kollbeck, Julia‐Kristin Graß, Jens Hillingsø, Luit Penninga
Abstract
Objectives This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the benefits and harms of de novo mTOR inhibitor‐based versus calcineurin inhibitor‐based immunosuppression for liver transplant recipients.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objectives This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the benefits and harms of de novo mTOR inhibitor‐based versus calcineurin inhibitor‐based immunosuppression for liver transplant recipients.
Key concepts: Immunosuppression, Calcineurin, Discovery and development of mTOR inhibitors, Medicine, Liver transplantation, Sirolimus, PI3K/AKT/mTOR pathway, Tacrolimus